Insider Trading Alert - NLY, LH, NATI, ARRS And AMP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Wednesday, Nov. 27, 2013, 160 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $788.24 to $484,583,953.98.

Highlighted Stocks Traded by Insiders:

Annaly Capital Management (NLY) - FREE Research Report

Lyght Rose-Marie who is Co-CIO at Annaly Capital Management bought 20,406 shares at $10.10 on Nov. 27, 2013. Following this transaction, the Co-CIO owned 163,011 shares meaning that the stake was reduced by 14.31% with the 20,406 share transaction.

The shares most recently traded at $10.15, up $0.05, or 0.49% since the insider transaction. Historical insider transactions for Annaly Capital Management go as follows:

  • 4-Week # shares bought: 238,406
  • 12-Week # shares bought: 238,406
  • 24-Week # shares bought: 447,224

The average volume for Annaly Capital Management has been 14.3 million shares per day over the past 30 days. Annaly Capital Management has a market cap of $9.6 billion and is part of the financial sector and real estate industry. Shares are down 27.49% year to date as of the close of trading on Wednesday.

Annaly Capital Management, Inc. owns, manages, and finances a portfolio of real estate related investments in United States. The stock currently has a dividend yield of 13.75%. The company has a P/E ratio of 3.0. Currently there is 1 analyst that rates Annaly Capital Management a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NLY - FREE

TheStreet Quant Ratings rates Annaly Capital Management as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, attractive valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Annaly Capital Management Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Laboratory Corporation of America Holdings (LH) - FREE Research Report

Brecher Mark E who is Chief Medical Officer at Laboratory Corporation of America Holdings sold 400 shares at $105.62 on Nov. 27, 2013. Following this transaction, the Chief Medical Officer owned 7,585 shares meaning that the stake was reduced by 5.01% with the 400 share transaction.

The shares most recently traded at $101.75, down $3.87, or 3.8% since the insider transaction. Historical insider transactions for Laboratory Corporation of America Holdings go as follows:

  • 4-Week # shares sold: 400
  • 12-Week # shares sold: 400
  • 24-Week # shares sold: 7,829

The average volume for Laboratory Corporation of America Holdings has been 660,100 shares per day over the past 30 days. Laboratory Corporation of America Holdings has a market cap of $8.9 billion and is part of the health care sector and health services industry. Shares are up 18.08% year to date as of the close of trading on Wednesday.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company has a P/E ratio of 16.8. Currently there are 3 analysts that rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LH - FREE

TheStreet Quant Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Laboratory Corporation of America Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

National Instruments Corporation (NATI) - FREE Research Report

Kodosky Jeffrey L who is Director at National Instruments Corporation sold 12,000 shares at $31.29 on Nov. 27, 2013. Following this transaction, the Director owned 989,180 shares meaning that the stake was reduced by 1.2% with the 12,000 share transaction.

Zogas Peter who is Senior Vice President at National Instruments Corporation sold 2,255 shares at $31.52 on Nov. 27, 2013. Following this transaction, the Senior Vice President owned 80,638 shares meaning that the stake was reduced by 2.72% with the 2,255 share transaction.

The shares most recently traded at $31.43, down $0.09, or 0.29% since the insider transaction. Historical insider transactions for National Instruments Corporation go as follows:

  • 4-Week # shares sold: 21,271
  • 12-Week # shares sold: 53,271
  • 24-Week # shares sold: 105,271

The average volume for National Instruments Corporation has been 410,400 shares per day over the past 30 days. National Instruments Corporation has a market cap of $3.9 billion and is part of the technology sector and computer software & services industry. Shares are up 21.93% year to date as of the close of trading on Wednesday.

National Instruments Corporation designs, manufactures, and sells tools to engineers and scientists worldwide. It offers LabVIEW, a system design software product for measurement and control; and LabVIEW Real-Time and LabVIEW FPGA that are strategic modular software add-ons. The stock currently has a dividend yield of 1.78%. The company has a P/E ratio of 57.2. Currently there is 1 analyst that rates National Instruments Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NATI - FREE

TheStreet Quant Ratings rates National Instruments Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full National Instruments Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

ARRIS Group (ARRS) - FREE Research Report

Geraci Marc S who is Treasurer at ARRIS Group sold 3,000 shares at $20.00 on Nov. 27, 2013. Following this transaction, the Treasurer owned 7,000 shares meaning that the stake was reduced by 30% with the 3,000 share transaction.

The shares most recently traded at $20.53, up $0.53, or 2.58% since the insider transaction. Historical insider transactions for ARRIS Group go as follows:

  • 4-Week # shares sold: 61,655
  • 12-Week # shares sold: 102,855
  • 24-Week # shares bought: 4,100
  • 24-Week # shares sold: 109,963

The average volume for ARRIS Group has been 1.7 million shares per day over the past 30 days. ARRIS Group has a market cap of $2.8 billion and is part of the technology sector and telecommunications industry. Shares are up 35.61% year to date as of the close of trading on Wednesday.

Arris Enterprises, Inc. develops, manufactures, and supplies telephony, data, video, construction, rebuild, and maintenance equipment primarily for cable system operators in the broadband communications industry worldwide. Currently there are 3 analysts that rate ARRIS Group a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARRS - FREE

TheStreet Quant Ratings rates ARRIS Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full ARRIS Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Ameriprise Financial (AMP) - FREE Research Report

Stewart David Kent who is Sr Vice Pres and Controller at Ameriprise Financial sold 1,000 shares at $108.63 on Nov. 27, 2013. Following this transaction, the Sr Vice Pres and Controller owned 20,543 shares meaning that the stake was reduced by 4.64% with the 1,000 share transaction.

The shares most recently traded at $108.92, up $0.29, or 0.27% since the insider transaction. Historical insider transactions for Ameriprise Financial go as follows:

  • 4-Week # shares sold: 43,528
  • 12-Week # shares sold: 102,291
  • 24-Week # shares sold: 120,063

The average volume for Ameriprise Financial has been 1.1 million shares per day over the past 30 days. Ameriprise Financial has a market cap of $21.1 billion and is part of the financial sector and financial services industry. Shares are up 73.29% year to date as of the close of trading on Wednesday.

Ameriprise Financial, Inc., through its subsidiaries, provides a range of financial products and services in the United States and internationally. The stock currently has a dividend yield of 1.92%. The company has a P/E ratio of 16.1. Currently there are 4 analysts that rate Ameriprise Financial a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMP - FREE

TheStreet Quant Ratings rates Ameriprise Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Ameriprise Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists